권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
Background: The neuroprotective effect of ginsenoside Rg1 is indeed one of the current research hotspots.
However, its limited ability to cross the blood-brain barrier results in low distribution within the brain. Thus, themechanism through which ginsenoside Rg1 affects the central nervous system needs further examination.
Methods: The LC-MS/MS analysis was used to detect the Kyn level. The expression of kynurenine aminotransferase2 (KAT2) and kynurenine 3-monooxygenase (KMO) were investigated by qRT-PCR and western blottinganalysis. The interaction between the transcription factor hepatocyte nuclear factor-4α (HNF4α) and peroxisomeproliferator-activated receptor-γ coactivator-1α (PGC1α) was explored by Co-IP assay. The HNF4α binding sitesin the KAT2 and KMO genes were analyzed by ChIP. In addition, we specifically knocked down HNF4α in theliver of mice by injecting adeno-associated virus into the tail vein.
Results: Ginsenoside Rg1 upregulated the expression of KAT2 and KMO, thereby increasing the metabolism ofKyn in the liver. Further exploring its mechanism, we discovered that ginsenoside Rg1 increased the expressionof KAT2 and KMO by promoting the interaction between the transcription factor HNF4α and PGC1α. HepaticHNF4α knockdown abolished the antidepressant effects induced by ginsenoside Rg1.
Conclusion: Our findings reveal a novel mechanism in which ginsenoside Rg1 upregulates KAT2 and KMOthrough the HNF4α/PGC1α pathway, reducing hepatic Kyn levels and subsequently alleviating depression.*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.